HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials

Fred M. Kusumoto; Hugh Calkins; John Boehmer; Alfred E. Buxton; Mina K. Chung; Michael R. Gold; Stefan H. Hohnloser; Julia Indik; Richard Lee; Mandeep R. Mehra; Venu Menon; Richard L. Page; Win Kuang Shen; David J. Slotwiner; Lynne Warner Stevenson; Paul D. Varosy; Lisa Welikovitch

doi:10.1016/j.hrthm.2014.03.041

HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials

Fred M. Kusumoto, Hugh Calkins, John Boehmer, Alfred E. Buxton, Mina K. Chung, Michael R. Gold, Stefan H. Hohnloser, Julia Indik, Richard Lee, Mandeep R. Mehra, Venu Menon, Richard L. Page, Win Kuang Shen, David J. Slotwiner, Lynne Warner Stevenson, Paul D. Varosy, Lisa Welikovitch

Research output: Contribution to journal › Article › peer-review

14 Scopus citations

Original language	English (US)
Pages (from-to)	1270-1303
Number of pages	34
Journal	Heart Rhythm
Volume	11
Issue number	7
DOIs	https://doi.org/10.1016/j.hrthm.2014.03.041
State	Published - Jul 2014
Externally published	Yes

Keywords

Defibrillator
Dual chamber
ICD
Myocardial infarction
Nonischemic cardiomyopathy
Revascularization

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine
Physiology (medical)

Access to Document

10.1016/j.hrthm.2014.03.041

Cite this

Kusumoto, F. M., Calkins, H., Boehmer, J., Buxton, A. E., Chung, M. K., Gold, M. R., Hohnloser, S. H., Indik, J., Lee, R., Mehra, M. R., Menon, V., Page, R. L., Shen, W. K., Slotwiner, D. J., Warner Stevenson, L., Varosy, P. D., & Welikovitch, L. (2014). HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials. Heart Rhythm, 11(7), 1270-1303. https://doi.org/10.1016/j.hrthm.2014.03.041

HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials. / Kusumoto, Fred M.; Calkins, Hugh; Boehmer, John; Buxton, Alfred E.; Chung, Mina K.; Gold, Michael R.; Hohnloser, Stefan H.; Indik, Julia; Lee, Richard; Mehra, Mandeep R.; Menon, Venu; Page, Richard L.; Shen, Win Kuang; Slotwiner, David J.; Warner Stevenson, Lynne; Varosy, Paul D.; Welikovitch, Lisa.

In: Heart Rhythm, Vol. 11, No. 7, 07.2014, p. 1270-1303.

Research output: Contribution to journal › Article › peer-review

Kusumoto, FM, Calkins, H, Boehmer, J, Buxton, AE, Chung, MK, Gold, MR, Hohnloser, SH, Indik, J, Lee, R, Mehra, MR, Menon, V, Page, RL, Shen, WK, Slotwiner, DJ, Warner Stevenson, L, Varosy, PD & Welikovitch, L 2014, 'HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials', Heart Rhythm, vol. 11, no. 7, pp. 1270-1303. https://doi.org/10.1016/j.hrthm.2014.03.041

Kusumoto, Fred M. ; Calkins, Hugh ; Boehmer, John ; Buxton, Alfred E. ; Chung, Mina K. ; Gold, Michael R. ; Hohnloser, Stefan H. ; Indik, Julia ; Lee, Richard ; Mehra, Mandeep R. ; Menon, Venu ; Page, Richard L. ; Shen, Win Kuang ; Slotwiner, David J. ; Warner Stevenson, Lynne ; Varosy, Paul D. ; Welikovitch, Lisa. / HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials. In: Heart Rhythm. 2014 ; Vol. 11, No. 7. pp. 1270-1303.

@article{5adcca327e38479188ab16d09c533449,

title = "HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials",

keywords = "Defibrillator, Dual chamber, ICD, Myocardial infarction, Nonischemic cardiomyopathy, Revascularization",

author = "Kusumoto, {Fred M.} and Hugh Calkins and John Boehmer and Buxton, {Alfred E.} and Chung, {Mina K.} and Gold, {Michael R.} and Hohnloser, {Stefan H.} and Julia Indik and Richard Lee and Mehra, {Mandeep R.} and Venu Menon and Page, {Richard L.} and Shen, {Win Kuang} and Slotwiner, {David J.} and {Warner Stevenson}, Lynne and Varosy, {Paul D.} and Lisa Welikovitch",

note = "Funding Information: Peer Reviewer Disclosure Table Peer Reviewer Consultant/Advisory Board Speakers׳ Bureau/Honoraria Research Grant Fellowship Support Board Mbs/Stock Options/Partner Others Sharon Hunt, MD None None None None None None John Burnett, MD 2: Chaire, Nile Therapeutics, Trevena, Bayer, Novartis, Merck, Anexon None None None 1: Zumbro Discovery 1: Intellectual property rights, Nile Therapeutics James R. Edgerton, MD 3: AtriCure 3: AtriCure None None None None Sana Al-Khatib, MD None None None None None None Anne Curtis, MD 1: Bristol-Myers Squibb, Janssen Pharmaceuticals, Biosense Webster, Inc., Sanofi Aventis, St. Jude Medical, Daiichi Sankyo, Pfizer, Jones & Bartlett None 2: Medtronic, Inc. None None None Valentin Fuster, MD, PhD None None None None None None David R. Holmes, Jr., MD None None None None None None Jodie L. Hurwitz, MD 1: Biosense Webster, Inc. 1: St. Jude Medical, Medtronic Inc., Boehringer Ingelheim None None None 0: Heart Rhythm Society 1: The Heart Hospital Baylor Plan, Medical City Hospital Gregory M. Marcus, MD None None 3: Medtronic, Inc., Gilead None None None 5: SentreHeart Simone Musco, MD None 1: Bristol-Myers Squibb, Pfizer None None None None Patrick T. O{\textquoteright}Gara, MD None None None None None 1: Lantheus Medical Imaging 2: National Institutes of Health Brian Olshansky, MD 1: Boston Scientific Corp., Boehringer Ingelheim, Medtronic, Inc., BioControl Medical, Ltd., Sanofi Aventis, Amarin None None None None 1: Sanofi Aventis, Boston Scientific, Amarin Marwan Refaat, MD None None None None None None Frederico Gentile, MD None None None None None None L. Samuel Wann, MD 1: United Healthcare None None None None None ",

year = "2014",

month = jul,

doi = "10.1016/j.hrthm.2014.03.041",

language = "English (US)",

volume = "11",

pages = "1270--1303",

journal = "Heart Rhythm",

issn = "1547-5271",

publisher = "Elsevier",

number = "7",

}

TY - JOUR

T1 - HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials

AU - Kusumoto, Fred M.

AU - Calkins, Hugh

AU - Boehmer, John

AU - Buxton, Alfred E.

AU - Chung, Mina K.

AU - Gold, Michael R.

AU - Hohnloser, Stefan H.

AU - Indik, Julia

AU - Lee, Richard

AU - Mehra, Mandeep R.

AU - Menon, Venu

AU - Page, Richard L.

AU - Shen, Win Kuang

AU - Slotwiner, David J.

AU - Warner Stevenson, Lynne

AU - Varosy, Paul D.

AU - Welikovitch, Lisa

N1 - Funding Information: Peer Reviewer Disclosure Table Peer Reviewer Consultant/Advisory Board Speakers׳ Bureau/Honoraria Research Grant Fellowship Support Board Mbs/Stock Options/Partner Others Sharon Hunt, MD None None None None None None John Burnett, MD 2: Chaire, Nile Therapeutics, Trevena, Bayer, Novartis, Merck, Anexon None None None 1: Zumbro Discovery 1: Intellectual property rights, Nile Therapeutics James R. Edgerton, MD 3: AtriCure 3: AtriCure None None None None Sana Al-Khatib, MD None None None None None None Anne Curtis, MD 1: Bristol-Myers Squibb, Janssen Pharmaceuticals, Biosense Webster, Inc., Sanofi Aventis, St. Jude Medical, Daiichi Sankyo, Pfizer, Jones & Bartlett None 2: Medtronic, Inc. None None None Valentin Fuster, MD, PhD None None None None None None David R. Holmes, Jr., MD None None None None None None Jodie L. Hurwitz, MD 1: Biosense Webster, Inc. 1: St. Jude Medical, Medtronic Inc., Boehringer Ingelheim None None None 0: Heart Rhythm Society 1: The Heart Hospital Baylor Plan, Medical City Hospital Gregory M. Marcus, MD None None 3: Medtronic, Inc., Gilead None None None 5: SentreHeart Simone Musco, MD None 1: Bristol-Myers Squibb, Pfizer None None None None Patrick T. O’Gara, MD None None None None None 1: Lantheus Medical Imaging 2: National Institutes of Health Brian Olshansky, MD 1: Boston Scientific Corp., Boehringer Ingelheim, Medtronic, Inc., BioControl Medical, Ltd., Sanofi Aventis, Amarin None None None None 1: Sanofi Aventis, Boston Scientific, Amarin Marwan Refaat, MD None None None None None None Frederico Gentile, MD None None None None None None L. Samuel Wann, MD 1: United Healthcare None None None None None

PY - 2014/7

Y1 - 2014/7

KW - Defibrillator

KW - Dual chamber

KW - ICD

KW - Myocardial infarction

KW - Nonischemic cardiomyopathy

KW - Revascularization

UR - http://www.scopus.com/inward/record.url?scp=84903155075&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903155075&partnerID=8YFLogxK

U2 - 10.1016/j.hrthm.2014.03.041

DO - 10.1016/j.hrthm.2014.03.041

M3 - Article

C2 - 24819194

AN - SCOPUS:84903155075

VL - 11

SP - 1270

EP - 1303

JO - Heart Rhythm

JF - Heart Rhythm

SN - 1547-5271

IS - 7

ER -